(1)
Di Brizzi, E. V.; Buononato, D.; Benvenuto, P.; Argenziano, G.; De Pasquale, R. .; Fiorella, C. S.; Gioffrè, C.; Musumeci, M. L.; Palazzo, G.; Zichichi, L.; Balato, A. Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis. Dermatol Pract Concept 2023, 13 (4), e2023215. https://doi.org/10.5826/dpc.1304a215.